Vol 8, No 4 (2007): Practical Diabetology
Review articles (translated)
Published online: 2007-05-17
Get Citation

Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes. Prevention of fluid retention

Guenther Boden, Carol Homko, Maria Mozzoli, Meijuan Zhang, Karen Kresge, Peter Cheung
Diabetologia Praktyczna 2007;8(4):135-146.
Vol 8, No 4 (2007): Practical Diabetology
Review articles (translated)
Published online: 2007-05-17

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

rosiglitazone; fenofibrate; diabetes type 2; FFA level

About this article
Title

Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes. Prevention of fluid retention

Journal

Clinical Diabetology

Issue

Vol 8, No 4 (2007): Practical Diabetology

Pages

135-146

Published online

2007-05-17

Bibliographic record

Diabetologia Praktyczna 2007;8(4):135-146.

Keywords

rosiglitazone
fenofibrate
diabetes type 2
FFA level

Authors

Guenther Boden
Carol Homko
Maria Mozzoli
Meijuan Zhang
Karen Kresge
Peter Cheung

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl